Article

Ethics

Editorial

days
Reset
12 results mentionning IRB approval 2020-016-03    X
# DOI Title Journal Date Cited/self/% Refs/self/% IRB Funding Notes
1 10.1002/jmv.29462 Resistance-associated mutations to the anti-SARS-CoV-2 agent nirmatrelvir: Selection not induction Journal Of Medical Virology 2024-02-16 2020-016-03
Email sent to the editor
2 10.1007/s00705-021-05331-4 Limited Spread Of A Rare Spike E484K-harboring SARS-CoV-2 In Marseille, France Archives of Virology 2022-01-27 3/3/100% 28/4/14% 2020-016-03
Email sent to the editor
3 10.1007/s11262-021-01877-2 Occurrence Of A Substitution Or Deletion Of SARS-CoV-2 Spike Amino Acid 677 In Various Lineages In Marseille, France Virus Genes 2021-11-27 8/0/0% 40/4/10% 2020-016-03 ANR 10-IAHU-03
Retrospective approval : Samples obtained on 2020-02 to 2021-04 and Approval on 2020-04-23
Healthy Patients
Email sent to the editor
4 10.1016/j.cmi.2021.05.006 Spreading Of A New SARS-CoV-2 N501Y Spike Variant In A New Lineage Clinical microbiology and infection 2021-09 28/14/50% 14/3/21% 2020-016-03
Reviewed in 56 days
Email sent to the editor
5 10.1016/j.cmi.2021.05.029 Clinical Outcomes In COVID-19 Patients Infected With Different SARS-CoV-2 Variants In Marseille, France Clinical microbiology and infection 2021-10 18/10/56% 8/3/38% 2020-016-03
Email sent to the editor
6 10.1016/j.cmi.2021.06.029 Does SARS-CoV-2 Re-Infection Depend On Virus Variant? Clinical microbiology and infection 2021-09 8/3/38% 6/3/50% 2020-016-03
Reviewed in 22 days
Email sent to the editor
7 10.1016/j.jinf.2024.106150 Role of SARS-CoV-2 mutations in the evolution of the COVID-19 pandemic Journal Of Infection 2024-03-31 2020-016-03
Retrospective approval : Samples obtained on 2020-02-24 to 2022-10-15 and Approval on 2020-04-23
8 10.1016/j.meegid.2021.105092 Clinical Outcomes In Patients Infected With Different SARS-CoV-2 Variants At One Hospital During Three Phases Of The COVID-19 Epidemic In Marseille, France Infection, Genetics and Evolution 2021-11 18/4/22% 27/12/44% 2020-016-03
Email sent to the editor
9 10.1016/j.micpath.2024.106561 Description of nasopharyngeal bacterial pathogens associated with different SARS-CoV-2 variants Microbial Pathogenesis 2024-02-20 2020-016-03
Healthy Patients
10 10.1016/j.tmaid.2021.102085 SARS-CoV-2 Variant From India To Marseille: The Still Active Role Of Ports In The Introduction Of Epidemics Travel Medicine and Infectious Disease 2021-07 11/8/73% 4/2/50% 2020-016-03
Reviewed in 8 days
Email sent to the editor
11 10.1016/j.tmaid.2022.102277 Introduction Of The SARS-CoV-2 Beta Variant From Comoros Into The Marseille Geographical Area Travel Medicine and Infectious Disease 2022-03 3/0/0% 22/9/41% 2020-016-03
Email sent to the editor
12 10.1080/22221751.2022.2052358 SARS-CoV-2 reinfection and COVID-19 severity Emerging Microbes & Infections 2022-03-21 2020-016-03
Retrospective approval : Samples obtained on 2020-03-19 to 2021-08-24 and Approval on 2020-04-23
Email sent to the editor
X
Article
IRB

IRB Approval